What's Happening?
Gaelic Laboratories has been awarded the BSI Kitemark Certification for Minimized Risk of Antimicrobial Resistance (AMR), recognizing its responsible antibiotic manufacturing practices and environmental risk management. This certification follows extensive
efforts to ensure the company's facilities meet stringent requirements for minimizing AMR risk and aquatic ecotoxicity. The certification aligns with the AMR Industry Association’s Antibiotic Manufacturing Standard, effective from January 2026, which provides guidance for responsible antibiotic production. Gaelic Laboratories' commitment to managing antibiotic discharge and environmental waste concerns is a significant step in addressing global AMR challenges.
Why It's Important?
The certification represents a gold-standard accreditation in the global antibiotic supply chain, highlighting the importance of responsible manufacturing practices in combating antimicrobial resistance. AMR poses a significant threat to global health, and companies like Gaelic Laboratories play a crucial role in mitigating this risk through sustainable practices. The certification not only assures partners and customers of the company's commitment to environmental risk management but also positions Gaelic Laboratories as a leader in the pharmaceutical industry’s efforts to curb AMR.
What's Next?
With the certification, Gaelic Laboratories is now eligible to apply for membership in the AMR Industry Alliance, a coalition of over 90 companies dedicated to providing sustainable solutions to combat AMR globally. This membership will enable Gaelic Laboratories to collaborate with other leading pharmaceutical manufacturers to support industry-wide efforts in fighting AMR. The company plans to leverage best practices to provide critical medicines while minimizing environmental impact, further advancing its role in the global fight against AMR.
